REVB · Revelation Biosciences, Inc. · Fails to Deliver
$3.71
+0.02 (+0.54%)
At close · Nov 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 5, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We do not anticipate that our current cash and cash equivalents balance will be sufficient to sustain operations within one year after the date that our unaudited financial statements for September 30, 2026 were issued, which raises substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Nov 5, 2026
Market Cap
$2.52M
Shares
683,442
Volume · Nov 20
1858
Avg daily vol (23 sessions)
20.32K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-10-27 | 1 | $3.54 | $4 |
| 2026-10-26 | 273 | $3.83 | $1,046 |
| 2026-10-23 | 423 | $3.68 | $1,557 |
| 2026-10-22 | 496 | $3.63 | $1,800 |
| 2026-10-21 | 10,059 | $3.65 | $36,715 |
| 2026-10-08 | 5,450 | $0.82 | $4,469 |
| 2026-09-28 | 3,096 | $0.89 | $2,755 |
| 2026-09-22 | 718 | $0.98 | $704 |
| 2026-09-21 | 3,133 | $0.93 | $2,914 |
| 2026-09-17 | 1,637 | $0.92 | $1,506 |
Showing 1–10 of 10 settlements
Key facts
CIK
1810560
CUSIP
76135L887
13F (30d)
16 filings
14 filers
Visit website
Investor relations